
What are drug-loaded embolic microspheres? Drug-loaded embolization microspheres are an interventional therapy technology used for tumor treatment.
It is a tiny sphere made of materials such as polymers or ceramics, with a certain size range, and is packed with anti-tumor drugs inside. Its main function is to embolize the blood supply vessels of the tumor and release drugs for local treatment. It can further improve the efficacy on the basis of traditional interventional therapy. It is an embolization material currently in clinical use internationally. Drug-loaded embolization microspheres are generally between 50 and 1200 μm in diameter. They are soft and deformable. They have a variety of different diameter specifications and can enter tumors to embolize tumor blood vessels. It is an embolic substance that can adsorb and carry chemotherapy drugs. It has a negative internal charge and good suspension. It can absorb anti-cancer drugs and release drugs from the inside of the tumor at a high concentration for a long time. After drug-loaded embolization microspheres enter the tumor blood vessels, they can embolize the tumor blood vessels on the one hand, and allow anti-cancer drugs to act inside the tumor for a long time on the other. The superposition of the two therapeutic effects can achieve better therapeutic effects and solve the problem of traditional intervention.
After drug-loaded embolization microspheres enter the tumor blood vessels, they can embolize the tumor blood vessels on the one hand, and allow anti-cancer drugs to act inside the tumor for a long time on the other. The superposition of the two therapeutic effects can achieve better therapeutic effects and solve the bottleneck problem of traditional interventional therapy alone.
>>For more cancer knowledge, please click on the online doctor for consultation
Therapeutic principles of interventional drug-loaded embolization microspheres
Interventional therapy can be divided into traditional embolization (c-TACE) and drug-loaded embolization microspheres (DEB-TACE) according to different embolization materials. Interventional drug-loaded embolization microspheres refer to the loading of anti-tumor drugs into the interior of the microspheres. Under the guidance of medical imaging equipment, the drug-loaded embolization microspheres are guided into the blood supply vessels of the tumor through the catheter. The specific gravity of the microspheres is the same as that of blood, and they can float forward in the blood vessels and embolize the tumor blood vessels with the blood flow. When the embolization is completed, the chemotherapy drugs adsorbed by the microspheres will be gradually exchanged by sodium ions in the body, and the chemotherapy drugs will be slowly released from the inside of the tumor for local treatment, achieving the purpose of killing the tumor.
Using this therapy, microspheres can block the nutrient supply blood vessels leading to cancer cells, and then slowly release chemotherapy drugs through leakage, degradation or stimulation response, which is equivalent to "starving" the tumor tissue on the one hand, and continuously "poisoning" the cancer cells on the other hand. It not only greatly reduces the toxic side effects of anti-cancer drugs on patients, but also improves the patient's quality of life.
Characteristics of drug-loaded embolic microspheres
1. Smooth surface, uniform size, perfectly round microspheres, with negative charge and good suspension
2. A high degree of vascular compliance facilitates "super-selective" targeted interventional therapy and more accurate embolization of target blood vessels supplying the tumor.
3. Diversity of drugs included
4. Combination of embolic agents and chemotherapy drugs
5. Fast drug loading and long drug release time
6. Increase the drug concentration in the tumor area, reduce the drug concentration in the systemic circulation, and significantly reduce drug toxicity.
Four major breakthroughs in interventional drug-loaded embolization microspheres
Breakthrough 1:Realize the dual function of "embolization of tumor supply arteries + anti-cancer drug release"
Breakthrough 2:Permanent embolization, completely blocking the target blood vessel, ensuring efficacy and avoiding "accidental embolization" and embolic agent "drift"
Breakthrough three:The drug loading speed is fast, the drug is released for a long time, and the drug can be released continuously for more than one month.
Breakthrough four:Compared with intravenous chemotherapy and traditional interventional therapy, it has the advantages of less side effects, less pain, and better therapeutic effects.
Six major advantages of interventional drug-loaded embolization microspheres
1. Safe, reliable, and the treatment process is less painful;
2. It is conducive to "super-selective" targeted interventional therapy, completely blocking the target blood vessels, ensuring curative effect, and avoiding "incorrect embolization" and "drift" of embolic agents;
3. Good conductivity, no abnormal obstruction of catheters and blood vessels, and deep embolism can be achieved
4. The medicine contained has a long sustained release time and can be released continuously for more than one month;
5. The drug is loaded with sustained release, with high local tumor concentration and low peripheral blood concentration, which greatly reduces the toxic and side effects of chemotherapy drugs;
6. It can be used as one of the important means of comprehensive treatment for intermediate and advanced tumors.
>>For more cancer knowledge, please click on the online doctor for consultation
Interventional drug-loaded embolization microspheres VS traditional interventional therapy
Comparative item | Drug-loaded embolization microsphere therapy (DEB-TACE) | traditional interventional therapy (c-TACE) |
Dosing method | One-time dual-vessel perfusion | Slowly inject into the artery supplying the tumor |
Treatment | Load anti-cancer drugs into microspheres, and the microspheres slowly release the drugs in the body | Directly inject anti-cancer drugs to kill tumors directly |
drug release pattern | sustained release | quick release |
embolic agent | Microsphere particles of different particle sizes (50-1200μm) | Lipiodol-chemotherapy drug mixture |
embolic effect | permanent (Drug-loaded microspheres are embolization materials that will not be absorbed or metabolized and can provide long-lasting embolization) | Not permanent (The embolic agent of traditional interventional therapy can only stay in the body for a maximum of 18 months, and will lose its efficacy after that time) |
side effect | Postoperative adverse reactions such as pain and nausea will be lighter and the side effects will be very mild. | Possibility of post-embolization syndrome, mild side effects from anticancer drugs |
Durability of drug effect | The drug-loaded embolization microspheres last for a long time, achieving a drug release effect of about one month, and the drug effect is highly durable. | After the embolization is completed, the chemotherapy drugs will be metabolized by the liver, and the drug effect will be less durable. |
Applicable groups for drug-loaded embolization microspheres:
1. Patients who are not suitable for or unwilling to undergo surgery or chemotherapy;
2. Salvage treatment
3. People who are intolerant to systemic chemotherapy
Applicable diseases of drug-loaded embolization microspheres:
Mainly used inliver cancer、 lung cancer、 breast cancer、 colorectal cancer、 cervical cancer、 Nasopharyngeal cancer、 Thyroid cancer、 prostate cancer、 stomach cancerand other solid tumors.
Compared with traditional interventional treatment, drug-loaded embolization microsphere interventional treatment is more suitable for patients with the following conditions:
1. For metastatic liver cancer, especially liver metastasis of colon cancer, interventional treatment with drug-loaded embolization microspheres has a positive effect
2. Primary liver cancer patients with Child-Pugh grade A or B liver function, ECOG score 0-2, and poor tolerance to anti-cancer drugs.
3. Patients with intermediate and advanced liver cancer with moderate tumor burden (less than 8 cm in diameter)
4. Patients with unresectable intrahepatic cholangiocarcinoma
Patient stories: Intervention of drug-loaded embolization microspheres gave them a new lease of life
1、Modern Cancer Hospital allows liver cancer patients who have been suffering from cancer for 5 years to experience the beauty of life again

>>For more cancer knowledge, please click on the online doctor for consultation
2. A huge tumor in the liver of a 70-year-old man shrunk by half after 4 months of treatment
Mr. Harun, a Malaysian liver cancer patient, is 70 years old. In January 2023, Mr. Harun was diagnosed by CT with a huge tumor in his liver. The local hospital recommended chemotherapy. Because Mr. Harun was weak and old, his family rejected the recommendation of chemotherapy.
In February 2023, Mr. Harlan arrived at St. Stamford Modern Cancer Hospital Guangzhou. After admission, considering his condition and age, the hospital's MDT team recommended that he receive interventional drug-loaded embolization microsphere therapy in conjunction with microwave ablation. After Mr. Harlan received treatment, he returned to the hospital for a follow-up visit in June 2023. He found that the tumor had been significantly reduced by nearly half and his condition was well controlled.

(Harlan CT comparison picture)
>>For more cancer knowledge, please click on the online doctor for consultation
Still have questions?
Reach our care team for personalized guidance on diagnosis, treatment, and insurance.
